Invasive Candidiasis in Various Patient Populations: Incorporating Non-Culture Diagnostic Tests into Rational Management Strategies
Mortality rates due to invasive candidiasis remain unacceptably high, in part because the poor sensitivity and slow turn-around time of cultures delay the initiation of antifungal treatment. β-d-glucan (Fungitell) and polymerase chain reaction (PCR)-based (T2Candida) assays are FDA-approved adjuncts...
Main Authors: | Cornelius J. Clancy, Ryan K. Shields, M. Hong Nguyen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-02-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | http://www.mdpi.com/2309-608X/2/1/10 |
Similar Items
-
Non-Culture Diagnostics for Invasive Candidiasis: Promise and Unintended Consequences
by: Cornelius J. Clancy, et al.
Published: (2018-02-01) -
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
by: Matteo Bassetti, et al.
Published: (2019-06-01) -
Intra-Abdominal Candidiasis
by: Afzal Azim, et al.
Published: (2017-07-01) -
Clinical Characteristic and Prevalence of Invasive Candidiasis Patient in Cipto Mangunkusumo Hospital
by: Kemal Fariz Kalista, et al.
Published: (2017-06-01) -
Systemic candidiasis in critical patients: risk predictors
by: Víctor Lazo, et al.
Published: (2018-01-01)